The HIV-positive tuberculosis treatment success rate in Japan is forecasted to gradually improve from 72% in 2024 to 78% by 2028. In 2023, the success rate stood at 70%, leading to a noticeable trend of improvement as the percentage increases year-on-year. Between 2024 and 2025, the success rate is expected to increase by around 1.39%, maintaining a similar growth pattern through to 2028. Over the five-year period, the compound annual growth rate (CAGR) is projected to be around 2.18%.

Future trends to watch for include:

The impact of new medical technologies and treatments on success rates.
Potential policy changes that could influence healthcare approaches to HIV and tuberculosis co-infection.
Trends in healthcare funding and resource allocation for infectious diseases in Japan.